Abemaciclib + Endocrine Therapy Improves Survival in HR

THURSDAY, Oct. 23, 2025 (HealthDay News) -- For patients with hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative, node-positive, hi